APA (7th ed.) Citation

Lin, C., Li, W., Wu, S., Chen, P. M. T., Chen, A. Y., Fann, C. S., & Chen, Y. A. (2026). The Usefulness of Metformin and Ganwei for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized, Placebo-Controlled Trial. International Journal of Molecular Sciences, 27(5), 2411. https://doi.org/10.3390/ijms27052411

Chicago Style (17th ed.) Citation

Lin, Chih-Lin, Wei-You Li, Shang-Jung Wu, Patricia M. T. Chen, Allan Y. Chen, Cathy Shen-Jang Fann, and Yi-Ming Arthur Chen. "The Usefulness of Metformin and Ganwei for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized, Placebo-Controlled Trial." International Journal of Molecular Sciences 27, no. 5 (2026): 2411. https://doi.org/10.3390/ijms27052411.

MLA (9th ed.) Citation

Lin, Chih-Lin, et al. "The Usefulness of Metformin and Ganwei for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized, Placebo-Controlled Trial." International Journal of Molecular Sciences, vol. 27, no. 5, 2026, p. 2411, https://doi.org/10.3390/ijms27052411.